Roivant Sciences (ROIV) president settles RSU tax bill with 46,878 shares

Rhea-AI Filing Summary

Roivant Sciences Ltd. director and President & CIO Mayukh Sukhatme had 46,878 Common Shares withheld on June 30, 2026 at $35.39 per share. This was a tax-withholding disposition tied to the vesting of previously granted RSUs, not an open-market trade. After this net settlement, he directly holds 18,630,739 Common Shares.

Insights

Insider trading analyst

Routine RSU tax withholding with large remaining stake.

Roivant Sciences' President & CIO Mayukh Sukhatme delivered 46,878 Common Shares at $35.39 per share to cover tax obligations on vested RSUs. The footnote clarifies this was a net settlement, a common mechanism for handling equity award taxes.

The transaction is coded "F", indicating payment of tax liability by delivering securities, not an open-market sale. Following the disposition, Sukhatme directly owns 18,630,739 Common Shares, so this event appears routine and does not materially alter his overall equity exposure based on the figures provided.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Sukhatme Mayukh

Role President & CIO

Type	Security	Shares	Price	Value
Tax Withholding	Common Shares	46,878	$35.39	$1.66M

Holdings After Transaction: Common Shares — 18,630,739 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares withheld for taxes: 46,878 shares Price per share for tax withholding: $35.39 per share Shares held after transaction: 18,630,739 shares +1 more

4 metrics

Shares withheld for taxes 46,878 shares Tax-withholding disposition on June 30, 2026

Price per share for tax withholding $35.39 per share Value used for RSU tax net settlement

Shares held after transaction 18,630,739 shares Direct Common Share holdings post-transaction

Tax-withholding share count (summary) 46,878 shares TaxWithholdingShares in transaction summary

Key Terms

RSUs, net settlement, tax withholding obligations, Common Shares, +1 more

5 terms

RSUs financial

"RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

net settlement financial

"Represents the "net settlement" by the Issuer of RSUs previously granted"

tax withholding obligations financial

"to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs"

Common Shares financial

"Common Shares, transaction code F, payment of exercise price or tax liability"

Common shares are the basic units of ownership in a company that give holders a claim on profits and a right to vote on key matters, like electing the board. Think of them as membership cards in a club: they let you share in successes and losses, but in a bankruptcy or liquidation they are paid after creditors and preferred shareholders, so their value can swing more and matters for assessing risk and potential return.

transaction code F financial

"transaction code F, Payment of exercise price or tax liability by delivering securities"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/02/2026 - 07:00 PM Accepted by SEC EDGAR 07/02/2026 - 07:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sukhatme Mayukh

(Last) (First) (Middle)

C/O ROIVANT SCIENCES LTD.

7TH FLOOR, 50 BROADWAY

(Street)

LONDON SW1H 0DB

(City) (State) (Zip)

UNITED KINGDOM

(Country)

2. Issuer Name and Ticker or Trading Symbol
Roivant Sciences Ltd. [ ROIV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & CIO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	06/30/2026		F		46,878(1)	D	$35.39	18,630,739	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.

Remarks:

	By: /s/ Matthew Gline, as Attorney-in-Fact for Mayukh Sukhatme	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Roivant Sciences (ROIV) report for Mayukh Sukhatme?

Roivant reported a tax-withholding share disposition for Mayukh Sukhatme. On June 30, 2026, 46,878 Common Shares were delivered at $35.39 per share to satisfy tax obligations related to vested RSUs, rather than being sold in the open market.

How many Roivant Sciences shares were used to cover Mayukh Sukhatme’s RSU taxes?

46,878 Roivant Sciences Common Shares were used for tax withholding. These shares were net settled by the issuer at $35.39 per share to satisfy applicable tax withholding obligations upon the vesting and settlement of previously granted RSUs.

Did Mayukh Sukhatme sell Roivant Sciences (ROIV) shares on the open market?

The filing does not show an open-market sale. The Form 4 records an F-code transaction where 46,878 shares were delivered to the issuer to cover tax liabilities from RSU vesting, a standard non-market mechanism for handling equity award taxes.

How many Roivant Sciences shares does Mayukh Sukhatme own after this transaction?

He directly owns 18,630,739 Common Shares after the transaction. The Form 4 states this post-transaction holding, indicating that despite the 46,878-share tax-withholding disposition, he retains a very substantial direct equity position in Roivant Sciences.

What does transaction code F mean in the Roivant Sciences Form 4 for ROIV?

Transaction code F indicates a tax-withholding disposition. In this case, 46,878 shares were delivered to the issuer at $35.39 per share to pay exercise price or tax liabilities associated with the vesting and settlement of RSUs granted to the reporting person.